Chand N, Pillar J, Diamantis W, Perhach J L, Sofia R D
Eur J Pharmacol. 1983 Dec 23;96(3-4):227-33. doi: 10.1016/0014-2999(83)90311-4.
Azelastine is a novel, orally effective, long-acting, antiallergic agent. The ability of azelastine to influence calcium ionophore A23187-induced histamine release from rat peritoneal mast cells was investigated and compared with selected antiallergic drugs. The concentrations of drugs required to inhibit A23187 (0.2 microM)-stimulated histamine release by 50% (IC50S, microM) were as follows: azelastine 5; diphenhydramine 52; and ketotifen 200. Theophylline and sodium cromoglycate in a concentration range of 0.1-1000 microM failed to exert any significant inhibition of histamine release. The inhibitory effects of azelastine on A23187-stimulated histamine release were antagonized by high concentrations of exogenous Ca2+ ions. These data suggest that azelastine inhibits A23187-stimulated histamine release by interfering with the influx of Ca2+ into the mast cells.
氮卓斯汀是一种新型的、口服有效的长效抗过敏药。研究了氮卓斯汀对钙离子载体A23187诱导的大鼠腹腔肥大细胞组胺释放的影响,并与选定的抗过敏药物进行了比较。抑制A23187(0.2微摩尔)刺激的组胺释放50%(IC50,微摩尔)所需的药物浓度如下:氮卓斯汀5;苯海拉明52;酮替芬200。浓度范围为0.1 - 1000微摩尔的茶碱和色甘酸钠未能对组胺释放产生任何显著抑制作用。高浓度的外源性Ca2 +离子可拮抗氮卓斯汀对A23187刺激的组胺释放的抑制作用。这些数据表明,氮卓斯汀通过干扰Ca2 +流入肥大细胞来抑制A23187刺激的组胺释放。